Zynex Inc Stock News

ENGLEWOOD, Colo. , April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pai

There are some industrial stocks that short sellers are targeting heavily in April this year. Short sellers often target stocks they perceive to be overvalued or companies facing significant challenge

Zynex (ZYXI) is a medical device manufacturer with products for pain management, injury rehab, and medical monitoring. CEO Thomas Sandgaard joins Oliver Renick to discuss the company's earnings.

Zynex, Inc. (ZYXI) Q4 2023 Earnings Call Transcript

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.17 per share. This compares to earnings of $0.20 per share a year ago.

ENGLEWOOD, Colo. , Feb. 22, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

The stock market recovery over the past couple of years has been anything but evenly-distributed. A handful of high-flying tech stocks dubbed the “Magnificent Seven” have largely powered the rebou

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.10 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.13 per share a year ago.

ENGLEWOOD, Colo. , Oct. 12, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

The Federal Reserve signaling interest rates could stay elevated for the long term coupled with relentless political infighting in Washington has brought another jolt of volatility to equities. This h

Zynex, Inc. is a pain management company that manufactures and markets medical devices for chronic and acute pain treatment. The stock has fallen by half since we took a first look at it in April desp

ENGLEWOOD, Colo. , Sept. 19, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

ENGLEWOOD, Colo., Sept. 5, 2023 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain

Zynex, Inc. (NASDAQ:ZYXI ) Q2 2023 Earnings Conference Call July 27, 2023 4:15 PM ET Company Participants Quinn Callanan - Investor Relations Thomas Sandgaard - Chairman, President and Chief Executive

Zynex Inc. (ZYXI) came out with quarterly earnings of $0.09 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.08 per share a year ago.